SEQUENT SCIENTIFIC
Back to Income Statement
|
SEQUENT SCIENTIFIC Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,551 Cr | ₹1,370 Cr | ₹1,421 Cr | ₹1,413 Cr | ₹1,362 Cr |
What is the latest Revenue of SEQUENT SCIENTIFIC ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹1,551 Cr |
| Mar2024 | ₹1,370 Cr |
| Mar2023 | ₹1,421 Cr |
| Mar2022 | ₹1,413 Cr |
| Mar2021 | ₹1,362 Cr |
How is Revenue of SEQUENT SCIENTIFIC Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,551 Cr | 13.26 | |
| Mar2024 | ₹1,370 Cr | -3.60 | |
| Mar2023 | ₹1,421 Cr | 0.57 | |
| Mar2022 | ₹1,413 Cr | 3.76 | |
| Mar2021 | ₹1,362 Cr | - | |
Compare Revenue of peers of SEQUENT SCIENTIFIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SEQUENT SCIENTIFIC | ₹5,615.6 Cr | -11.9% | 9.7% | 15.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹425,102.0 Cr | -0.7% | 4.3% | 0.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,299.0 Cr | -0.6% | -2.6% | 6.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,753.0 Cr | 0.4% | 4.7% | 19.8% | Stock Analytics | |
| CIPLA | ₹121,735.0 Cr | -1.3% | -4.8% | 2.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,155.0 Cr | -1.1% | -3.7% | 2.5% | Stock Analytics | |
SEQUENT SCIENTIFIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SEQUENT SCIENTIFIC | -11.9% |
9.7% |
15.6% |
| SENSEX | -0.1% |
0% |
9% |
You may also like the below Video Courses